Axis Bank Ltd. News and Updates

Name: Latest research reports of Axis Bank Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Axis Bank Ltd.
Rating: 5
Author: ICICI Securities Limited

Keep track of all breaking news on Axis Bank Ltd. from all sources in a single place.

Load latest

Axis Bank Ltd.

05 Nov 2018

1158.90

-1.02%

Axis Bank

Buy: Axis Bank Ltd.

ICICI Securities Limited

Axis Bank reported a stellar set of numbers Asset quality improved further in Q2FY19. Slippages came in at | 2777 crore (lowest in last several quarters) vs. | 4337 crore in Q1FY19. Corporate slippages were at | 1090 crore. Total 88% of this came from disclosed BB & below accounts. The bank's BB & below rated book was at | 8860 crore. This is 1.7% of the bank's gross customer assets vs. 7.3% peak reached in June 2016 Exposure to IL&FS; is relatively lower at | 825 crore. Of this | 238 is...

Number of FII/FPI investors increased from 1551 to 1575 in Jun 2025 qtr.

Axis Bank Ltd.

05 Nov 2018

1158.90

-1.02%

Result Review of Axis Bank

Accumulate: Axis Bank Ltd.

Target

IDBI Capital

Significant improvement is seen on asset quality. Slippages have eased to 2.4% as against 3.9% last quarter. Similarly GNPA as well as provision coverage has improved sequentially. Loan growth is moderate at 11%, driven by retail and SME segment. NII growth of 15% is in line with our expectations; whereas PAT growth of 83% is 4% ahead of our estimates. We have cut our slippage estimate by 100bps to 3% for FY19. We have raised our ABV estimates by 3%/1% for FY19/FY20. Given the recent price correction, we upgrade our rating to ACCUMULATE marginally increasing our TP to Rs665 (Rs655...

Axis Bank Ltd. is trading at high day volume of 12.8M.

Axis Bank Ltd.

03 Nov 2018

1158.90

-1.02%

Axis Bank (2QFY19): Like a phoenix. Maintain BUY

Buy: Axis Bank Ltd.

HDFC Securities

Maintain BUY with a TP of Rs 718 (2.5x Sept-20E ABV of Rs 287). AXSBs 2Q performance was characterized by continued amelioration in asset quality, improving growth and visible focus on the granular business in line with our expectations. We expect this trend to strengthen as Amitabh Choudhary takes charge.

Axis Bank Ltd. has an average target of 1302.77 from 13 brokers.

Axis Bank Ltd.

02 Nov 2018

1158.90

-1.02%

Axis Bank eyes major turnaround as retail, SME drive growth, slippages fall

Business Standard

The private bank's net profit surged 83% to Rs 78.9 mn thanks to growing interest income and better provisioning

Axis Bank Ltd. is trading at high day volume of 12.8M.

Axis Bank: Fall in slippages offers respite to earnings

Business Line | 02 Nov 2018 4 more

Axis Bank Ltd.

02 Nov 2018

1158.90

-1.02%

Axis Bank

Hold: Axis Bank Ltd.

Target

Centrum Broking

We retain HOLD on Axis Bank with TP revised upwards to Rs560 (valued at 2x FY20E ABV) . Q2'19 results were in-line with our estimates on revenue / operating front. Slippages came in lower (2.4% of loans); provision coverage therein has improved further. The share of vulnerable pool is now at a meagre 1.7% of customer assets and provides greater comfort. Capital position remains strong and will cushion asset growth in the credit up-cycle. While we see levers in place, we would await for better clarity on long-term growth strategy for the bank under the leadership of the new management (change of guard will be effective from...

Axis Bank Ltd. is trading at high day volume of 12.8M.

Axis Bank Ltd.

01 Nov 2018

1158.90

-1.02%

Axis Bank (Update): A new era begins Upgrade to BUY

Buy: Axis Bank Ltd.

Recommendation Target

HDFC Securities

The stock may remain volatile in the near term, in line with asset quality developments. Our TP is 718 (on an upgraded multiple of 2.5x Sept-20E ABV of Rs 287). Over FY16-18, AXSB has stumbled over several setbacks, namely (1) Corporate NPAs have blown up to 15%, (2) Very adverse Asset Quality Divergence reporting, (3) Several cases of non-compliance at branches during demonetization, and (4) The RBIs nudge to the AXSB Board to reconsider extension of the MD & CEOs tenure.